帕博利珠单抗联合化疗应用于早期三阴性乳腺癌新辅助治疗中的首个前瞻性随机对照Ⅲ期临床研究

    The First Prospective Randomized Controlled Phase ⅢClinical Study of Pembrolizumab Combined With Chemotherapy as Neoadjuvant Treatment for Early Triple-Negative Breast Cancer

    /

    返回文章
    返回